Diagnostic challenges in atypical breast cancer presentations initially managed as occult breast cancer: a case report of two patients

Background Occult breast cancer (OBC) is a rare breast carcinoma presenting with regional or distant metastasis in the absence of a clinically or radiologically detectable primary breast tumor. In practice, atypical presentations initially managed as OBC pose substantial diagnostic challenges. Subcutaneous nodules near the breast boundary may represent either isolated metastases or primary carcinomas arising in peripheral or ectopic breast tissue, and can mimic cutaneous adnexal malignancies. Furthermore, when an ambiguous breast lesion is biopsied without marker clip placement, subsequent neoadjuvant therapy can obscure the distinction between true OBC and a primary breast tumor achieving complete pathological regression. Case presentation We report two patients initially managed as OBC. Case 1, a 57-year-old woman, presented with a solitary subcutaneous nodule on the left anterior chest wall. Histopathological examination revealed invasive ductal carcinoma (no special type). Immunohistochemistry (IHC) showed estrogen receptor (ER) (+), GATA-binding protein 3 (GATA-3) (+), E-cadherin (+), progesterone receptor (PR) (-), and human epidermal growth factor receptor 2 (HER2) (-). Myoepithelial markers (calponin, p63, cytokeratin 5/6 [CK5/6]) and p40 were negative. Postoperative positron emission tomography-computed tomography (PET-CT) detected no hypermetabolic extramammary lesions. Although managed as an isolated subcutaneous metastasis of OBC (cT0cN0M1), a primary carcinoma in superior peripheral or ectopic breast tissue (pT1c cN0 M0) could not be excluded. Case 2, a 68-year-old woman, presented with fixed right axillary lymphadenopathy and an ipsilateral breast mass on magnetic resonance imaging (MRI) and computed tomography (CT). Pre-treatment vacuum-assisted biopsy (VAB) of the breast lesion showed adenosis with focal atypical ductal hyperplasia (ADH) without marker clip placement, whereas axillary core biopsy confirmed metastatic carcinoma (ER-, PR-, HER2 3+, GATA-3+, TRPS1+). After neoadjuvant anti-HER2 chemo-targeted therapy, the mastectomy specimen showed stromal fibrosis and foam cell hyperplasia without residual carcinoma, while microscopic metastasis (≤ 2.0 mm) persisted in three of six axillary nodes. This raised a diagnostic dilemma between true OBC and a primary breast carcinoma achieving breast pathological complete response (ypT0 ypN1mi). Conclusion Evaluating atypical breast malignancies requires comprehensive IHC profiling, biopsy clip localization, and close clinical, radiological, and pathological correlation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-18
DOI
https://doi.org/10.3389/fonc.2026.1958442
Primary Topic
Breast Lesions and Carcinomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic challenges in atypical breast cancer presentations initially managed as occult breast cancer: a case report of two patients

Yongcheng Zhang, Huiying Chen, Junhao Liao
2 links
Frontiers in Oncology
Breast Lesions and Carcinomas
article

Diagnostic challenges in atypical breast cancer presentations initially managed as occult breast cancer: a case report of two patients

Yongcheng Zhang, Huiying Chen, Junhao Liao
article en

Abstract

Background Occult breast cancer (OBC) is a rare breast carcinoma presenting with regional or distant metastasis in the absence of a clinically or radiologically detectable primary breast tumor. In practice, atypical presentations initially managed as OBC pose substantial diagnostic challenges. Subcutaneous nodules near the breast boundary may represent either isolated metastases or primary carcinomas arising in peripheral or ectopic breast tissue, and can mimic cutaneous adnexal malignancies. Furthermore, when an ambiguous breast lesion is biopsied without marker clip placement, subsequent neoadjuvant therapy can obscure the distinction between true OBC and a primary breast tumor achieving complete pathological regression. Case presentation We report two patients initially managed as OBC. Case 1, a 57-year-old woman, presented with a solitary subcutaneous nodule on the left anterior chest wall. Histopathological examination revealed invasive ductal carcinoma (no special type). Immunohistochemistry (IHC) showed estrogen receptor (ER) (+), GATA-binding protein 3 (GATA-3) (+), E-cadherin (+), progesterone receptor (PR) (-), and human epidermal growth factor receptor 2 (HER2) (-). Myoepithelial markers (calponin, p63, cytokeratin 5/6 [CK5/6]) and p40 were negative. Postoperative positron emission tomography-computed tomography (PET-CT) detected no hypermetabolic extramammary lesions. Although managed as an isolated subcutaneous metastasis of OBC (cT0cN0M1), a primary carcinoma in superior peripheral or ectopic breast tissue (pT1c cN0 M0) could not be excluded. Case 2, a 68-year-old woman, presented with fixed right axillary lymphadenopathy and an ipsilateral breast mass on magnetic resonance imaging (MRI) and computed tomography (CT). Pre-treatment vacuum-assisted biopsy (VAB) of the breast lesion showed adenosis with focal atypical ductal hyperplasia (ADH) without marker clip placement, whereas axillary core biopsy confirmed metastatic carcinoma (ER-, PR-, HER2 3+, GATA-3+, TRPS1+). After neoadjuvant anti-HER2 chemo-targeted therapy, the mastectomy specimen showed stromal fibrosis and foam cell hyperplasia without residual carcinoma, while microscopic metastasis (≤ 2.0 mm) persisted in three of six axillary nodes. This raised a diagnostic dilemma between true OBC and a primary breast carcinoma achieving breast pathological complete response (ypT0 ypN1mi). Conclusion Evaluating atypical breast malignancies requires comprehensive IHC profiling, biopsy clip localization, and close clinical, radiological, and pathological correlation.

Frontiers in OncologyVol. 16
First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
Good health and well-being
Breast Lesions and Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon